Veerhealth Care Limited (VEERHEALTH.BO)
INR 13.26
(3.51%)
INR 13.26
(3.51%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 62.78 Million INR | 64.26% |
| 2022 | 38.22 Million INR | -38.35% |
| 2021 | 62 Million INR | 32.3% |
| 2020 | 46.86 Million INR | 10.84% |
| 2019 | 42.28 Million INR | 46.89% |
| 2018 | 28.78 Million INR | 75.84% |
| 2017 | 16.36 Million INR | 691.92% |
| 2016 | 2.06 Million INR | -83.85% |
| 2015 | 12.79 Million INR | 3.33% |
| 2014 | 12.38 Million INR | 605.75% |
| 2013 | 1.75 Million INR | -89.83% |
| 2012 | 17.26 Million INR | 6294.94% |
| 2011 | 269.97 Thousand INR | -61.32% |
| 2010 | 698 Thousand INR | -92.86% |
| 2009 | 9.78 Million INR | -19.64% |
| 2008 | 12.17 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -218.38 Million INR | -447.86% |
| 2023 Q4 | 62.78 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 18.77 Million INR | 0.0% |
| 2023 FY | 62.78 Million INR | 64.26% |
| 2022 Q2 | 58.43 Million INR | 0.0% |
| 2022 FY | 38.22 Million INR | -38.35% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 38.22 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 62 Million INR | 0.0% |
| 2021 FY | 62 Million INR | 32.3% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 45.69 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 46.86 Million INR | 10.84% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 46.86 Million INR | 0.0% |
| 2020 Q2 | 43.62 Million INR | 0.0% |
| 2019 Q4 | 42.28 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 39.82 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 42.28 Million INR | 46.89% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 28.78 Million INR | 0.0% |
| 2018 Q2 | 15.43 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 28.78 Million INR | 75.84% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 16.36 Million INR | 691.92% |
| 2017 Q2 | 26.49 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 16.36 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 2.24 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 2.06 Million INR | -83.85% |
| 2016 Q2 | 13.02 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 FY | 12.79 Million INR | 3.33% |
| 2015 Q2 | 24.5 Million INR | 0.0% |
| 2015 Q4 | 12.79 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2014 FY | 12.38 Million INR | 605.75% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q4 | 12.38 Million INR | 0.0% |
| 2014 Q2 | 16.7 Million INR | 0.0% |
| 2013 FY | 1.75 Million INR | -89.83% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 16.5 Million INR | 0.0% |
| 2013 Q4 | 1.75 Million INR | 0.0% |
| 2012 FY | 17.26 Million INR | 6294.94% |
| 2012 Q4 | 17.26 Million INR | 0.0% |
| 2011 Q4 | 269.97 Thousand INR | 0.0% |
| 2011 FY | 269.97 Thousand INR | -61.32% |
| 2010 FY | 698 Thousand INR | -92.86% |
| 2009 FY | 9.78 Million INR | -19.64% |
| 2008 FY | 12.17 Million INR | 0.0% |
| 2008 Q4 | 12.17 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Colinz Laboratories Limited | 24.1 Million INR | -160.444% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 92.465% |
| DECIPHER LABS LIMITED | 117.72 Million INR | 46.672% |
| Phaarmasia Limited | 211.49 Million INR | 70.316% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -199.095% |
| Deccan Health Care Limited | 111.33 Million INR | 43.612% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 96.222% |
| Trident Lifeline Limited | 331.26 Million INR | 81.048% |
| Zenlabs Ethica Limited | 301.35 Million INR | 79.167% |
| Bharat Parenterals Limited | 2.65 Billion INR | 97.637% |
| Vivanza Biosciences Limited | 148.63 Million INR | 57.761% |
| Crestchem Limited | 23.94 Million INR | -162.162% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | 68.858% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 94.449% |
| Anuh Pharma Limited | 1.54 Billion INR | 95.936% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -607.619% |
| Add-Shop E-Retail Limited | 159.2 Million INR | 60.566% |
| Bacil Pharma Limited | 1.12 Million INR | -5460.673% |
| Makers Laboratories Limited | 569.18 Million INR | 88.97% |
| BDH Industries Limited | 312.53 Million INR | 79.913% |
| Beryl Drugs Limited | 85.63 Million INR | 26.69% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 93.749% |
| Cian Healthcare Limited | 1.03 Billion INR | 93.93% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -2850.188% |
| Denis Chem Lab Limited | 289.82 Million INR | 78.338% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -368.333% |
| Evoq Remedies Limited | 116.23 Million INR | 45.987% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 96.627% |
| Godavari Drugs Limited | 957.86 Million INR | 93.446% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | 61.169% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | 68.192% |
| Hindustan Bio Sciences Limited | 25.7 Million INR | -144.27% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 94.064% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 93.699% |
| Lactose (India) Limited | 536.39 Million INR | 88.296% |
| Medi-Caps Limited | 63.01 Million INR | 0.375% |
| MedPlus Health Services Limited | 14.27 Billion INR | 99.56% |
| Mercury Laboratories Limited | 171.18 Million INR | 63.327% |
| Norris Medicines Limited | 278.17 Million INR | 77.431% |
| PANJON LTD. | 25.38 Million INR | -147.331% |
| Parmax Pharma Limited | 117.56 Million INR | 46.601% |
| Patidar Buildcon Limited | 25.57 Million INR | -145.503% |
| PRAVEG LIMITED | 767.53 Million INR | 91.821% |
| Roopa Industries Limited | 493.08 Million INR | 87.268% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | 59.514% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 95.816% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | 87.145% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -20896.656% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | 68.917% |
| Smruthi Organics Limited | 485.72 Million INR | 87.075% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -49.576% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 96.338% |
| Sunil Healthcare Limited | 902.83 Million INR | 93.046% |
| Syschem (India) Limited | 1.07 Billion INR | 94.137% |
| Trimurthi Limited | 101.36 Thousand INR | -61837.648% |
| Vikram Thermo (India) Limited | 291.47 Million INR | 78.461% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | 64.16% |
| Zenith Healthcare Limited | 24.03 Million INR | -161.202% |
| Zenotech Laboratories Limited | 156.64 Million INR | 59.923% |
| Concord Drugs Limited | 249.88 Million INR | 74.877% |
| Gennex Laboratories Limited | 535.21 Million INR | 88.27% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -319.12% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -17.024% |
| Parnax Lab Limited | 1.17 Billion INR | 94.637% |
| Trinity League India Limited | 876 Thousand INR | -7066.667% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | 46.897% |
| Tyche Industries Limited | 101.64 Million INR | 38.234% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 96.342% |
| Transchem Limited | 6.72 Million INR | -834.226% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | 69.881% |
| Panchsheel Organics Limited | 340.2 Million INR | 81.546% |
| Coral Laboratories Limited | 281.83 Million INR | 77.725% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 96.927% |
| Natural Capsules Limited | 1.47 Billion INR | 95.75% |
| Auro Laboratories Limited | 433.09 Million INR | 85.504% |